A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,137,204 shares of TAK stock, worth $173 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,137,204
Previous 13,126,608 0.08%
Holding current value
$173 Million
Previous $170 Million 9.9%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$13.0 - $15.08 $137,748 - $159,787
10,596 Added 0.08%
13,137,204 $187 Million
Q2 2024

Aug 13, 2024

BUY
$12.6 - $13.67 $58,942 - $63,948
4,678 Added 0.04%
13,126,608 $170 Million
Q1 2024

May 14, 2024

SELL
$13.89 - $15.04 $16.3 Million - $17.7 Million
-1,175,875 Reduced 8.22%
13,121,930 $182 Million
Q4 2023

Feb 13, 2024

BUY
$13.36 - $15.43 $6.73 Million - $7.77 Million
503,446 Added 3.65%
14,297,805 $204 Million
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $97,965 - $106,373
6,518 Added 0.05%
13,794,359 $213 Million
Q2 2023

Aug 11, 2023

BUY
$15.57 - $17.11 $3.24 Million - $3.57 Million
208,381 Added 1.53%
13,787,841 $217 Million
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $167 Million - $180 Million
10,903,323 Added 407.43%
13,579,460 $224 Million
Q4 2022

Feb 14, 2023

BUY
$12.42 - $15.62 $33.2 Million - $41.8 Million
2,676,137 New
2,676,137 $41.8 Million
Q1 2021

May 14, 2021

SELL
$16.71 - $19.9 $1.09 Million - $1.3 Million
-65,430 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$15.39 - $18.97 $154,746 - $190,743
10,055 Added 18.16%
65,430 $1.19 Million
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $69,118 - $77,565
4,042 Added 7.87%
55,375 $1 Million
Q2 2020

Aug 14, 2020

BUY
$14.59 - $19.5 $228,654 - $305,604
15,672 Added 43.95%
51,333 $930,000
Q1 2020

May 15, 2020

BUY
$13.02 - $20.31 $138,207 - $215,590
10,615 Added 42.38%
35,661 $557,000
Q4 2019

Feb 18, 2020

BUY
$16.88 - $20.83 $92,671 - $114,356
5,490 Added 28.07%
25,046 $492,000
Q3 2019

Nov 14, 2019

BUY
$16.15 - $17.99 $315,829 - $351,812
19,556 New
19,556 $339,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.